Form 8-K - Current report:
SEC Accession No. 0001477932-24-007310
Filing Date
2024-11-15
Accepted
2024-11-15 15:01:52
Documents
17
Period of Report
2024-11-13
Items
Item 4.01: Changes in Registrant's Certifying Accountant
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K gdwl_8k.htm   iXBRL 8-K 25156
2 LETTER gdwl_ex161.htm EX-16.1 4721
8 gdwl_ex161img2.jpg GRAPHIC 2136
  Complete submission text file 0001477932-24-007310.txt   152284

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA gdwl-20241113.xsd EX-101.SCH 5720
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE gdwl-20241113_lab.xml EX-101.LAB 13717
5 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE gdwl-20241113_cal.xml EX-101.CAL 898
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE gdwl-20241113_pre.xml EX-101.PRE 8614
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE gdwl-20241113_def.xml EX-101.DEF 2099
19 EXTRACTED XBRL INSTANCE DOCUMENT gdwl_8k_htm.xml XML 3666
Mailing Address 581 BOSTON MILLS ROAD, SUITE 300 HUDSON OH 44236
Business Address 581 BOSTON MILLS ROAD, SUITE 300 HUDSON OH 44236 440-666-7999
GOLDENWELL BIOTECH, INC. (Filer) CIK: 0001800373 (see all company filings)

EIN.: 842896086 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-56275 | Film No.: 241467516
SIC: 2000 Food and Kindred Products
(CF Office: 04 Manufacturing)